KarenSMarderMD

Movement Disorder, Dementia & Geriatrics

Professor of Neurology at Columbia University Medical Center; Chief of the Division of Aging and Dementia in the Department of Neurology

Request Appointment

Overview of Dr. Marder

Dr. Karen Marder is a neurologist in New York, NY and is affiliated with multiple hospitals in the area, including New York-Presbyterian Hospital and NewYork-Presbyterian/Columbia University Irving Medical Center. She received her medical degree from Weill Cornell Medicine and has been in practice 34 years. She is one of 484 doctors at New York-Presbyterian Hospital and one of 211 doctors at NewYork-Presbyterian/Columbia University Irving Medical Center who specialize in Neurology. She has more than 100 publications and over 500 citings.

Office
710 W 168th St
New York, NY 10032
Book by Phone+1(708) 980-0114

Fax+1 212-305-1145

Education & Training

New York Presbyterian Hospital (Columbia Campus)Residency, Neurology, 1984 - 1987
Weill Cornell MedicineClass of 1983

Certifications & Licensure

FL State Medical License 2023 - Present
NY State Medical License 1984 - 2027
NJ State Medical License 2022 - 2025
American Board of Psychiatry and Neurology Neurology

Awards, Honors, & Recognition

America's Top Doctors Castle Connolly, 2013-2014
Top Doctors: New York Metro Area Castle Connolly, 2002-2014
New York Magazine: Top Doctors Castle Connolly, 2012-2013
Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2012
Super Doctor SuperDoctors.com
Join now to see all

Clinical Trials

Neurobiological Predictors of Huntington's Disease (PREDICT-HD) Start of enrollment: 2002 Aug 01
Active, not recruiting
Consortium On Risk for Early-onset Parkinson's Disease (CORE PD) Start of enrollment: 2004 Jul 01
Unknown status
Creatine Safety, Tolerability, & Efficacy in Huntington's Disease (CREST-E) Start of enrollment: 2009 Sep 01
Terminated
Phase 3
Enroll -HD: A Prospective Registry Study in a Global Huntington's Disease Cohort Start of enrollment: 2012 Jul 01
Recruiting
Join now to see all

Publications & Presentations

PubMed

113 citations
A Genome-Wide Scan of Ashkenazi Jewish Crohn's Disease Suggests Novel Susceptibility Loci
Eimear E. Kenny, Itsik Pe'er, Amir Karban, Laurie J. Ozelius, Adele A. Mitchell
Plos Genetics. 2012-03-08
1781 citations
Diagnostic Criteria for Mild Cognitive Impairment in Parkinson’s Disease: Movement Disorder Society Task Force Guidelines
Irene Litvan, Jennifer G. Goldman, Alexander I. Tröster, Ben Schmand, Daniel Weintraub
Movement Disorders. 2012-03-01
228 citations
Interrater reliability of the unified Parkinson's disease rating scale motor examination
Marcus Richards, Karen Marder, Lucien J. Cote, Richard Mayeux
Movement Disorders. 1994-01-01

Press Mentions

Parkinson's Disease Foundation Announces $4 Million in Research Investments to Solve, Treat and End Parkinson's DiseaseJune 9th, 2016
Diagnosing and Treating Early,Stage Alzheimer'sFebruary 14th, 2007
Following a Mediterranean Diet Not Associated with Delay to Clinical Onset of Huntington's DiseaseFebruary 10th, 2016

Grant Support

Columbia University Medical Center - Weill Cornell Medical Center Next SiteNational Institute Of Neurological Disorders And Stroke2011
Genetic Epidemiology Of Parkinson'S DiseaseNational Institute Of Neurological Disorders And Stroke2010
Genetic Epidemiology Of Parkinson'S DiseaseNational Institute Of Neurological Disorders And Stroke2004–2008
Selegiline Transdermal SystemNational Center For Research Resources2004–2005
PREDICT-HDNational Center For Research Resources2004–2005
Pilot Huntington'S At Risk Observational Study (PHAROS)National Center For Research Resources2004–2005
Neurocognitive Function, HIV Load And Surrogate MarkersNational Center For Research Resources2004
Genetic Epidemiology Of Parkinson'S DiseaseNational Center For Research Resources2004
CrestNational Center For Research Resources2004
Genetic Epidemiology Of Parkinsons DiseaseNational Institute Of Neurological Disorders And Stroke1998–2003
Pilot Huntington'S At Risk Observational Study (PHAROS)National Center For Research Resources2000–2002
Plasma Viral Load And Cognitive Decline In Advanced HIV InfectionNational Institute Of Neurological Disorders And Stroke1999–2002
Pilot Efficacy Study Of CPI 1189 In HIV Infect Indiv W/ Cognit &MotoNational Center For Research Resources1999–2002
Neurocognitive Function, HIV Load &Surrogate MarkersNational Center For Research Resources1999–2002
Genetic Epidemiology Of Parkinsons DiseaseNational Center For Research Resources1999–2002
Phase III Trial Of 1592U89 In HIV-1 Patients With AIDS DementiaNational Center For Research Resources1998–2002
Co-Enzyme Q10 And Remacemide--Evaluation In Huntington'S DiseaseNational Center For Research Resources1998–2002
Selegiline Transdermal System Treatment Of HIV Associated Cognitive ImpairmentNational Center For Research Resources1998–2000
Lexipafant In HIV DementiaNational Center For Research Resources1998–1999
Plasma Viral Load And Cognitive Decline In Advanced HIV InfectionNational Institute Of Neurological Disorders And Stroke1998
Genetic / Environmental Influences--Dementia In Parkinson'S DiseaseNational Institute On Aging1996–1998
Randomized Trial Of OPG 14117 In Huntingtons DiseaseNational Center For Research Resources1996
ACTG 243--Pml StudyNational Center For Research Resources1996